반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드
날짜
제약/바이오/
임상시험
Contract Manufacturing: Opportunities and Threats – March 2023 04-19-2023
Contract Service Agreements – March 2023 04-19-2023
Arrowhead Pharmaceuticals to Target Unmet Needs in Rare Lipid Disorders 04-19-2023
March Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q1 2023 04-19-2023
Bayer Plans to Scale Back Women’s Health R&D 04-19-2023
Over 2,000 Drugs in Japan Undergo an Average Reduction of 9.0% in April, Including NHI-Related Price Adjustments 04-18-2023
Multiple Sclerosis Market to Generate Sales of $29.8 Billion by 2030 04-18-2023
Combination of Merck’s Keytruda with Eisai’s Lenvima Fail Phase III Trial in Front-line Melanoma 04-17-2023
Global Risk Report (Quarterly Update) Q4 2022 04-06-2023
Maven Clinic, a Telehealth Platform, Is the First Women's and Family Health Company in the US to Reach Unicorn Status 04-03-2023
New Drug Approvals and Their Contract Manufacture: 2023 Edition 04-03-2023
FDA $7.2 Billion Plans for 2024: Disclose Contract Manufacturers, Stricter on Shortages and Recalls 03-31-2023
 
질환별
Unmet Needs in the Obesity Market 04-13-2023
Respiratory Syncytial Virus (RSV): Competitive Landscape 04-10-2023
Multiple Sclerosis: Seven-Market Drug Forecast and Market Analysis to 2030 – Update 04-07-2023
Ulcerative Colitis: Eight-Market Drug Forecast and Market Analysis 04-04-2023
Mucopolysaccharidosis II (MPS II): Competitive Landscape 03-31-2023
Systemic Lupus Erythematosus and Lupus Nephritis: Seven-Market Drug Forecast and Market Analysis to 2031 03-31-2023
컨퍼런스/
심포지엄/

학회 등
AACR 2023: Moderna’s mRNA-4157 Paves the Way for Personalized Cancer Vaccines in High-Risk Melanoma 04-18-2023
AD/PD 2023: What Role Could Blood-Based Biomarkers Play in the Future Diagnosis of AD? 04-03-2023
AD/PD 2023: Challenges in Clinical Trial Design for DMTs in PD 04-03-2023

 

 

반응형

+ Recent posts